Daru Jahnavi, Colman Katherine, Stanworth Simon J, De La Salle Barbara, Wood Erica M, Pasricha Sant-Rayn
Women's Health Research Unit, Barts and the London School of Medicine, Queen Mary University of London, London, United Kingdom.
Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia.
Am J Clin Nutr. 2017 Dec;106(Suppl 6):1634S-1639S. doi: 10.3945/ajcn.117.155960. Epub 2017 Oct 25.
Determination of iron status in pregnancy and in young children is essential for both clinical and public health practice. Clinical diagnosis of iron deficiency (ID) through sampling of bone marrow to identify the absence of body iron stores is impractical in most cases. Serum ferritin (SF) concentrations are the most commonly deployed indicator for determining ID, and low SF concentrations reflect a state of iron depletion. However, there is considerable variation in SF cutoffs recommended by different expert groups to diagnose ID. Moreover, the cutoffs used in different clinical laboratories are heterogeneous. There are few studies of diagnostic test accuracy to establish the sensitivity and specificity of SF compared with key gold standards (such as absent bone marrow iron stores, increased intestinal iron absorption, and hemoglobin response to SF) among noninflamed, outpatient populations. The limited data available suggest the commonly recommended SF cutoff of <15 μg/L is a specific but not sensitive cutoff, although evidence is limited. Data from women during pregnancy or from young children are especially uncommon. Most data are from studies conducted >30 y ago, do not reflect ethnic or geographic diversity, and were performed in an era for which laboratory methods no longer reflect present practice. Future studies to define the appropriate SF cutoffs are urgently needed and would also provide an opportunity to compare this indicator with other established and emerging iron indexes. In addition, future work would benefit from a focus on elucidating cutoffs and indexes relevant to iron adequacy.
确定孕妇和幼儿的铁状态对于临床和公共卫生实践都至关重要。在大多数情况下,通过骨髓采样来临床诊断缺铁(ID)以确定体内铁储存的缺失是不切实际的。血清铁蛋白(SF)浓度是确定ID最常用的指标,低SF浓度反映铁耗竭状态。然而,不同专家小组推荐的用于诊断ID的SF临界值存在很大差异。此外,不同临床实验室使用的临界值也不一致。在无炎症的门诊人群中,与关键金标准(如骨髓铁储存缺失、肠道铁吸收增加以及血红蛋白对SF的反应)相比,关于确定SF敏感性和特异性的诊断试验准确性的研究很少。现有有限的数据表明,尽管证据有限,但通常推荐的<15μg/L的SF临界值是一个特异性但不敏感的临界值。来自孕妇或幼儿的数据尤其少见。大多数数据来自30多年前进行的研究,不能反映种族或地域多样性,并且是在一个实验室方法已不再反映当前实践的时代进行的。迫切需要开展未来研究来确定合适的SF临界值,这也将提供一个机会,将该指标与其他既定和新兴的铁指标进行比较。此外,未来的工作将受益于专注于阐明与铁充足相关的临界值和指标。